Abstract
Prognosis — the prediction of the duration, course, and outcome of disease in an individual patient — is an essential part of medical practice. The more precise the methods available are the better our possibilities for individualized therapy. In breast cancer this is a challenging problem. Mammography has resulted in the detection of an increased proportion of small, preclinical turaprs for which the proper treatment is controversial (1). Concepts regarding breast cancer surgery have been changing (2,3). In addition, the recent improvement in hormonal therapy, including the development of antiestrogen compounds and cytotoxic therapies, have widened the therapeutic spectrum. However, traditional ways of subgrouping patients into various prognostic groups by clinical staging and histomorphological grading have been proven to be inaccurate and too subjective for prognostication in the individual patient (4–8). Therefore, new approaches for tumor grading in breast cancer have been proposed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Letton, A.H., Mason, E.M. Cancer 46:980–982, 1980.
Harris, J.R., Recht, A., Schnitt, S., Connolly, J., Silver, B., Come, S., Henderson, C. Seventh Annual San Antonio Breast Cancer Symposium. Breast Cancer Res. Treat 5:245–255, 1985.
Leis Jr, HP. Breast Cancer Res. Treat 1:5–15, 1981.
Bloom, H.J.G., Field, J.R. Cancer 6:1580–1589, 1971.
Sharkey, F.E. Breast Cancer Res. Treat 2: 299–322, 1982.
Stenkvist, B., Westman-Naeser, S., Vegelius, J., Holmquist, J., Nordin, B., Bengtsson, E. and Eriksson, O. J. Clin. Pathol. 32:979–985, 1979.
Stenkvist, B., Bengtsson, E., Eriksson, O., Jarkrans, T., Nordin, B., Westman-Naeser, S. Clin. Pathol. 36:392–398, 1983.
Schiödt, T. Munksgaard, Copenhagen, 1966.
Bishop, H.M., Blarney, R.W., Elston, C.W., Haybittle, J.L., Nicholson, R.J., Griffiths, K. Lancet ii, 283–284, 1979.
Croton R., Cooke, T., Holt, S., George, W.D., Nocolson, R., Griffiths, K. Br. Med. J. 1289–1291, 1981.
Furmanski, P., Saunders, D., Brooks, S., Rich, M. Cancer 46:2794–2796, 1980.
Godolphin, W., Elwood, J.M., Spinelli, J.J. Int. J. Cancer 28:677–683, 1981.
Knight, W.A., Livingston, R.B., Gregory, E.J., McGuire, W.L. Cancer Res. 37:4669–4671, 1977.
Adami, H-O., Graffman, S., Lindgren, A., Sällström, J. Breast Cancer Res. Treat. 5:293–300, 1985.
Adami, H-O., Killander, D. Acta Chir. Scand. Suppl. 519:25–34, 1984.
Parl, F.F., Schmidt, P.B., Dupont, W.D., Wagner, R.K. Cancer 54:2237–2242, 1984.
Atkin, N.B. Br. Med. J. 86:271–272, 1972.
Atkin, N.B., Kay, R. Br. J. Cancer 40:210–221, 1979.
Auer, G., Caspersson, T., Wallgren, A. Anal. Quant. Cytol. 3: 161–165, 1980.
Cohn, K., Bäckdahl, M., Forsslund, G., Auer, G., Lundell, G., Löwhagen, T., Tallroth, E., Willems, J.S., Zetterberg, A., Granberg, P-O. World J. Surg. 8:470–480, 1984.
Coulson, P.B., Thornthwaite, J.T., Wooley, T.W., Sugarbaker, E.V., Seckinger, D. Cancer Res. 44:4187–4196, 1984.
Erhardt, K., Auer, G., Björkholm, E., Forsslund, G., Moberger, B., Silfverswärd, C., Wicksell, G., Zetterberg, A. Cancer Res 44:2198–2202, 1984.
Erhardt, K., Auer, G., Fallenius, A., Folin, A., Forsslund, G., Silfverswärd, C, Zetterberg, A. Am. Clin. Oncol. 9(2), 1986.
Ewers, S.B., Långström, E., Baldetorp, B., Killander, D. Cytometry 5: 408–419, 1984.
Hedley, D.W., Rugg, CA., Ng, A.B.P., Taylor, I.W. Cancer Res. 44:5395–5398, 1984.
Kreicbergs, A., Söderberg, G., Zetterberg, A. Anal. Quant. Cytol. 4:271–278, 1980.
Krug, H., Schönfelder, M. Acta Histochem. Suppl. Band XXX, 117–127, 1984.
Moberger, B., Auer, G., Forsslund, G., Moberger, G. Cytometry 5:430–436, 1984.
Tavares, A.S., Costa, J., de Carvalho, A., Reis, M. Br. J. Cancer 20:438–441, 1966.
Tavares, A.S., Costa, J., Costa, J.M. J. Urol. 109:676–679, 1973.
Tribukait, B. Med. Oncol. & Tumor Pharmaco Ther. 1:211–218, 1984.
Wolley, R.C., Schreiber, K., Koss, L.G., Karas, M., Sherman, A. JNCI 69:15–22, 1982.
Zetterberg, A., Esposti, L.P. Scand. J. Urol. Nephrol. 55:53–58, 1980.
Caspersson, T. Skand. Arch. Physiol. 73, Suppl. 8, 1936.
Caspersson, T., Kudynowski, J. Int. Rev. Exp. Pathol. 21:1–54, 1980.
Caspersson, T., Lomakka, G. In: Introduction to Quantitative Cytochemistry II. (Eds. G.L. Wied, G.F. Bahr), Academic Press, New York, 1970, pp. 27–56.
Caspersson, T., Lomakka, G. Ann. NY Acad. Sci. 92:449–463, 1962.
Caspersson, T. Cancer Res. 32:2341–2355, 1979.
Caspersson, T., Auer, G., Fallenius, A., Kudynowski, J. Histochem. J. 15:337–362, 1983.
Hansemann, D., von. Virchows Arch. Path. Anat. 119:299–326, 1890.
Hansemann, D., von. Virchows Arch. Path. Anat. 129:436–449, 1892.
Atkin, N.B., Richards, B.M. Br. J. Cancer 10:769–786, 1956.
Leuchtenberger, C, Leuchtenberger, R., Davis, A.M. Am. J. Pathol. 30:65–85, 1954.
Richards, B.M., Atkin, N.B. Acta Unio. Int. Cancrum 16:124–128, 1960.
Deshpande, N., Mitchell, I., Allen, D., Millis, R. Int. J. Cancer 32:693–696, 1983.
Klintenberg, C, Wallgren, A., Bjelkenkrantz, K., Carstensen, J., Humla, S., Nordenskjöld, B., Skoog, L. Acta Radiol. Oncol. 24:253–258, 1985.
UICC International Union Against Cancer: TNM Classification of malignant tumors. Third Edition, Geneva, 1982.
de Schryver, A. Int. J. Radiat. Oncol. Biol. Phys. 1:601–609, 1976.
Strender, L.E., Wallgren, A., Arndt, J., Arner, O., Bergström, J., Blomstedt, B., Granberg, P-O., Nilsson, B., Räf, L., Silfverswärd, C. Int. J. Radiat. Oncol. Biol. Phys. 7:1319–1325, 1981.
Decosse, J.J., Aiello, N. J. Histochem. Cytochem. 14:601–604, 1966.
Gaub, J., Auer, G., Zetterberg, A. Exp. Cell. Res. 92:323–332, 1975.
Thorud, E., Fossa, S.D., Vaage, S., Kaalhus, O., Knudsen, O.S., Boermer, O., Shoaib, M.C. Cancer 52:808–811, 1986.
Peto, R., Pike, M.C, Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J., Smith, P.G. Br. J. Cancer 35:1–39, 1977.
Cox, D, R. J. R. Statist. Soc. (B) 34:187–220, 1972.
Jakobsen, A., Skovgaard Poulsen, H., Lindegaard Madsen, E., Ellebaek Petersen, S., Sommer Hansen, H. Acta Rad. Oncol. 22:103–107, 1984.
Fisher, B., Slack, N.H. Surg. Gynecol. Obstet. 131:79–88, 1970.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Fallenius, A., Auer, G. (1988). Nuclear DNA Content and Prognosis in Breast Cancer. In: Rich, M.A., Hager, J.C., Lopez, D.M. (eds) Breast Cancer: Scientific and Clinical Progress. Developments in Oncology, vol 56. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1753-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1753-1_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8984-5
Online ISBN: 978-1-4613-1753-1
eBook Packages: Springer Book Archive